Market Share of Global Patient Derived Xenograft Models Industry
The patient-derived xenograft market is consolidated in nature due to the presence of a few key companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold significant market shares and are well known, including Champions Oncology, Inc., Crown Bioscience, Inc., Charles River Laboratories, Inc., EPO Berlin-Buch GmbH, Hera BioLabs, Oncodesign, Pharmatest Services Ltd, Urolead and Xentech among others.
Patient Derived Xenograft Models Market Leaders
-
Champions Oncology, Inc.
-
Crown Bioscience, Inc.
-
Charles River Laboratories, Inc.
-
EPO Berlin-Buch GmbH
-
Oncodesign
*Disclaimer: Major Players sorted in no particular order